All data are based on the daily closing price as of October 4, 2024
j

JLK

322510.KQ
10.00 USD
-0.51
-4.85%

Overview

Last close
10.00 usd
Market cap
172.33M usd
52 week high
28.89 usd
52 week low
4.04 usd
Target price
N/A usd

Valuation

P/E
N/A
Forward P/E
N/A
Price/Sales
144.6413
Price/Book Value
39.5859
Enterprise Value
190.89M usd
EV/Revenue
158.0956
EV/EBITDA
-13.3411

Key financials

Revenue TTM
1.21M usd
Gross Profit TTM
3.32M usd
EBITDA TTM
-7.21M usd
Earnings per Share
N/A usd
Dividend
N/A usd
Total assets
32.37B usd
Net debt
N/A usd

About

JLK, Inc. provides diagnosis support to the patients with it AI-driven solutions in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides the on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatment, and medical service in brain diseases, such as ischemic stroke, hemorrhagic stroke, brain aneurysm, and Alzheimer's disease; and in lung diseases, coronary artery disease, prostate cancer, and digital pathology. The company was formerly known as JLK INSPECTION Co.,Ltd. JLK, Inc. is headquartered in Cheongju, South Korea.
  • Symbol
    322510.KQ
  • Exchange
    KQ
  • Isin
    KR7322510009
  • Country
    South Korea
  • Sector
    Industrials
  • Industry
    Conglomerates
  • CEO
    Mr. Won-Tae Kim
  • Headquarter
    Cheongju
  • Web site
    https://www.jlkgroup.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top